Safety, Tolerability, and Pharmacokinetics of XXB750 in Healthy Participants
Clinical trial NCT06558097 · COMPLETED
Trial details
- NCT number
- NCT06558097
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2023-03-02
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.